1. Home
  2. PHI vs MRUS Comparison

PHI vs MRUS Comparison

Compare PHI & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHI
  • MRUS
  • Stock Information
  • Founded
  • PHI 1928
  • MRUS 2003
  • Country
  • PHI Philippines
  • MRUS Netherlands
  • Employees
  • PHI N/A
  • MRUS N/A
  • Industry
  • PHI Telecommunications Equipment
  • MRUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHI Telecommunications
  • MRUS Health Care
  • Exchange
  • PHI Nasdaq
  • MRUS Nasdaq
  • Market Cap
  • PHI 5.0B
  • MRUS 4.1B
  • IPO Year
  • PHI 1953
  • MRUS 2016
  • Fundamental
  • Price
  • PHI $23.24
  • MRUS $66.16
  • Analyst Decision
  • PHI
  • MRUS Strong Buy
  • Analyst Count
  • PHI 0
  • MRUS 13
  • Target Price
  • PHI N/A
  • MRUS $88.54
  • AVG Volume (30 Days)
  • PHI 56.9K
  • MRUS 652.6K
  • Earning Date
  • PHI 08-12-2025
  • MRUS 08-12-2025
  • Dividend Yield
  • PHI 5.36%
  • MRUS N/A
  • EPS Growth
  • PHI 14.93
  • MRUS N/A
  • EPS
  • PHI 2.54
  • MRUS N/A
  • Revenue
  • PHI $3,804,539,911.00
  • MRUS $54,732,000.00
  • Revenue This Year
  • PHI $3.85
  • MRUS $67.27
  • Revenue Next Year
  • PHI $2.33
  • MRUS $0.49
  • P/E Ratio
  • PHI $8.90
  • MRUS N/A
  • Revenue Growth
  • PHI 2.38
  • MRUS 42.77
  • 52 Week Low
  • PHI $20.29
  • MRUS $33.19
  • 52 Week High
  • PHI $29.05
  • MRUS $67.25
  • Technical
  • Relative Strength Index (RSI)
  • PHI 65.73
  • MRUS 72.89
  • Support Level
  • PHI $22.67
  • MRUS $64.61
  • Resistance Level
  • PHI $23.25
  • MRUS $67.25
  • Average True Range (ATR)
  • PHI 0.36
  • MRUS 2.21
  • MACD
  • PHI 0.13
  • MRUS 0.62
  • Stochastic Oscillator
  • PHI 90.10
  • MRUS 91.86

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: